» Articles » PMID: 27683235

Induction of Varicella Zoster Virus DNA Replication in Dissociated Human Trigeminal Ganglia

Overview
Journal J Neurovirol
Publisher Springer
Specialties Microbiology
Neurology
Date 2016 Sep 30
PMID 27683235
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Varicella zoster virus (VZV), a human neurotropic alphaherpesvirus, becomes latent after primary infection and reactivates to produce zoster. To study VZV latency and reactivation, human trigeminal ganglia removed within 24 h after death were mechanically dissociated, randomly distributed into six-well tissue culture plates and incubated with reagents to inactivate nerve growth factor (NGF) or phosphoinositide 3-kinase (PI3-kinase) pathways. At 5 days, VZV DNA increased in control and PI3-kinase inhibitor-treated cultures to the same extent, but was significantly more abundant in anti-NGF-treated cultures (p = 0.001). Overall, VZV DNA replication is regulated in part by an NGF pathway that is PI3-kinase-independent.

Citing Articles

Antiviral Targeting of Varicella Zoster Virus Replication and Neuronal Reactivation Using CRISPR/Cas9 Cleavage of the Duplicated Open Reading Frames 62/71.

Wu B, Yee M, Goldstein R, Kinchington P Viruses. 2022; 14(2).

PMID: 35215971 PMC: 8880005. DOI: 10.3390/v14020378.


Varicella Zoster Virus Neuronal Latency and Reactivation Modeled in Vitro.

Goldstein R, Kinchington P Curr Top Microbiol Immunol. 2021; 438:103-134.

PMID: 34904194 DOI: 10.1007/82_2021_244.


Herpesviral Latency-Common Themes.

Weidner-Glunde M, Kruminis-Kaszkiel E, Savanagouder M Pathogens. 2020; 9(2).

PMID: 32075270 PMC: 7167855. DOI: 10.3390/pathogens9020125.


Modeling Varicella Zoster Virus Persistence and Reactivation - Closer to Resolving a Perplexing Persistent State.

Laemmle L, Goldstein R, Kinchington P Front Microbiol. 2019; 10:1634.

PMID: 31396173 PMC: 6667558. DOI: 10.3389/fmicb.2019.01634.


Current In Vitro Models to Study Varicella Zoster Virus Latency and Reactivation.

Baird N, Zhu S, Pearce C, Viejo-Borbolla A Viruses. 2019; 11(2).

PMID: 30691086 PMC: 6409813. DOI: 10.3390/v11020103.


References
1.
Gershon A, Breuer J, Cohen J, Cohrs R, Gershon M, Gilden D . Varicella zoster virus infection. Nat Rev Dis Primers. 2016; 1:15016. PMC: 5381807. DOI: 10.1038/nrdp.2015.16. View

2.
Eaton H, Saffran H, Wu F, Quach K, Smiley J . Herpes simplex virus protein kinases US3 and UL13 modulate VP11/12 phosphorylation, virion packaging, and phosphatidylinositol 3-kinase/Akt signaling activity. J Virol. 2014; 88(13):7379-88. PMC: 4054420. DOI: 10.1128/JVI.00712-14. View

3.
Stevens J, Haarr L, PORTER D, Cook M, Wagner E . Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans. J Infect Dis. 1988; 158(1):117-23. DOI: 10.1093/infdis/158.1.117. View

4.
Cohrs R, Laguardia J, Gilden D . Distribution of latent herpes simplex virus type-1 and varicella zoster virus DNA in human trigeminal Ganglia. Virus Genes. 2005; 31(2):223-7. DOI: 10.1007/s11262-005-1799-5. View

5.
Tiwari V, Shukla D . Phosphoinositide 3 kinase signalling may affect multiple steps during herpes simplex virus type-1 entry. J Gen Virol. 2010; 91(Pt 12):3002-9. PMC: 3052565. DOI: 10.1099/vir.0.024166-0. View